Literature DB >> 4171294

Occlusion of plasma proteins by human fibrin: studies using trace-labelled proteins.

E Regoeczi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4171294     DOI： 10.1111/j.1365-2141.1968.tb01498.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

1.  Interaction of amorphous calcium phosphate with fibrin in vitro causes decreased fibrinolysis and altered protease profiles: implications for atherosclerotic disease.

Authors:  G S Makowski; M L Ramsby
Journal:  Inflammation       Date:  2001-10       Impact factor: 4.092

2.  Binding of latent matrix metalloproteinase 9 to fibrin: activation via a plasmin-dependent pathway.

Authors:  G S Makowski; M L Ramsby
Journal:  Inflammation       Date:  1998-06       Impact factor: 4.092

3.  Amorphous calcium phosphate-mediated binding of matrix metalloproteinase-9 to fibrin is inhibited by pyrophosphate and bisphosphonate.

Authors:  G S Makowski; M L Ramsby
Journal:  Inflammation       Date:  1999-08       Impact factor: 4.092

4.  Binding of matrix metalloproteinase 9 to fibrin is mediated by amorphous calcium-phosphate.

Authors:  G S Makowski; M L Ramsby
Journal:  Inflammation       Date:  1998-12       Impact factor: 4.092

5.  Labelled polyvinylpyrrolidone as an in vivo indicator of reticuloendothelial activity.

Authors:  E Regoeczi
Journal:  Br J Exp Pathol       Date:  1976-08

6.  Thromboembolic complications in myelomatosis.

Authors:  D Catovsky; N B Ikoku; W R Pitney; D A Galton
Journal:  Br Med J       Date:  1970-08-22

7.  Differential effect of calcium phosphate and calcium pyrophosphate on binding of matrix metalloproteinases to fibrin: comparison to a fibrin-binding protease from inflammatory joint fluids.

Authors:  G S Makowski; M L Ramsby
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.